Drug intelligence / Profile preview

pancuronium

Development stage
Approved
Lead developer
Organon
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Administration
Intravenous
01

Overview

Pancuronium is a nondepolarizing neuromuscular blocking agent of the aminosteroid class, used as an adjunct to general anesthesia to facilitate tracheal intubation and provide skeletal muscle relaxation during surgery or mechanical ventilation. It acts as a competitive antagonist at nicotinic acetylcholine receptors at the neuromuscular junction, preventing acetylcholine from binding and thereby inhibiting depolarization of muscle fibers. This results in muscle paralysis without causing initial fasciculations. Pancuronium has minimal histamine release but exhibits slight vagolytic activity, which can increase heart rate and blood pressure. Its onset is relatively slow (2–6 minutes), with a long duration of action (up to 100 minutes for clinical effect). The drug’s effects can be reversed by anticholinesterase agents such as neostigmine or pyridostigmine[1][2][4][5].

Brand names
Pavulon
Other names
pancuronium bromide
02

Targets

Muscle-type nicotinic acetylcholine receptor

Beyond the preview

Go deeper on pancuronium.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on pancuronium.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call